Detalhe da pesquisa
1.
Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease.
J Biol Chem
; 299(12): 105382, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866628
2.
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer.
Int J Mol Sci
; 22(4)2021 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33672769
3.
Crystal structure of archaeal homolog of proteasome-assembly chaperone PbaA.
Biochem Biophys Res Commun
; 453(3): 493-7, 2014 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25285636
4.
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.
PLoS One
; 19(2): e0293548, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359047
5.
Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease.
bioRxiv
; 2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292860
6.
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.
bioRxiv
; 2023 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37547005
7.
Reviewing Antiviral Research against Viruses Causing Human Diseases - a Structure-Guided Approach.
Curr Mol Pharmacol
; 15(2): 306-337, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348638
8.
Supramolecular tholos-like architecture constituted by archaeal proteins without functional annotation.
Sci Rep
; 10(1): 1540, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001743
9.
Conversion of functionally undefined homopentameric protein PbaA into a proteasome activator by mutational modification of its C-terminal segment conformation.
Protein Eng Des Sel
; 31(1): 29-36, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301037